Evidence map›Paper›PMID 42616872›Full record

ArticleScience advances2026

SKI is critical to counter TGF-β signaling to promote T cell function and autoimmunity.

Junying Wang, Ziyi Chen, Hongrui Li, Zengli Guo, Gang Wang, Junnian Zheng, Yisong Y Wan

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Junying WangLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0002-9289-7702
Ziyi ChenLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0003-2933-3274
Hongrui LiLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0002-2571-1883
Zengli GuoLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0003-2950-4790
Gang WangLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0001-6020-7263
Junnian ZhengCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.ORCID 0000-0003-0208-6410
Yisong Y WanLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0003-4346-9717

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Functional protein networks underlying T cell growth, proliferation and differentiationR01AI123193 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yisong Wan · 2017 to 2026
$3.8M
TGF-b superfamily signaling in controlling Th17 cell function in autoimmune neuroinflammationR01AI160774 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WAN, YISONG · 2021 to 2025
$1.9M
Biodegradable polymeric microparticles comprised of acetalated dextran induce immune toleranceR01AI187725 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Kristy M Ainslie · 2025 to 2026
$1.0M
NCI NIH HHS P30 CA016086NIAID NIH HHS R01 AI123193NIAID NIH HHS R01 AI160774NIAID NIH HHS R01 AI187725
6 · The paper itself

Abstract

Transforming growth factor-β (TGF-β) is central to suppressing T cell function to maintain tolerance and immune homeostasis. The current TGF-β signaling paradigm is however inadequate in explaining how TGF-β controls T cell function. Here, we found a previously unappreciated, SKI-dependent mechanism of TGF-β signaling to better explain how TGF-β restricts T cell function to bolster tolerance. We found that SKI protein was up-regulated in activated T cells and down-regulated in response to TGF-β, indicating a reciprocal relationship between SKI and TGF-β in controlling T cell function. T cell-specific SKI deletion ameliorated spontaneous lethal autoimmunity due to T cell-specific TGFβRII deletion and mitigated MOG/CFA-induced experimental autoimmune encephalomyelitis. SKI was required for activation-induced T cell function and related molecular programs. Therefore, inhibition of TGFβR not only results in the loss of Smad-dependent function but, more importantly, leads to the gain of SKI-dependent activity, which is essential for T cell-mediated autoimmunity. A critical mechanism underlying TGF-β-mediated suppression of T cell function is overcoming SKI activity.

Indexed as

AutoimmunityDNA-Binding ProteinsProto-Oncogene ProteinsSignal TransductionT-LymphocytesTransforming Growth Factor betaAnimalsEncephalomyelitis, Autoimmune, ExperimentalLymphocyte ActivationMiceReceptor, Transforming Growth Factor-beta Type IIDNA-Binding ProteinsProto-Oncogene ProteinsReceptor, Transforming Growth Factor-beta Type IISki protein, mouseTransforming Growth Factor beta

Identifiers

PMID42616872
PMCPMC13488881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.